Arkolith/Insider Trading/BNKL/Form 4

Gaston-Dreyfus Remi

Director, 10% OwnerBionik Laboratories Corp. (BNKL) · full profile →Form 4 · filed Jun 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Conversion(C)78K$9.50$740K1.6M

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-073083) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML